Phenolic Profile, EPR Determination, and Antiproliferative Activity against Human Cancer Cell Lines of Anthyllis vulneraria Extracts

Molecules. 2022 Nov 3;27(21):7495. doi: 10.3390/molecules27217495.

Abstract

In the current work, the leaf and flower extracts of Anthyllis vulneraria were evaluated for their chemical characterization using HPLC-MS and for their radical scavenging capacity toward methoxy radicals produced by a Fenton-type reaction using an electron paramagnetic resonance (EPR) spectroscopy assay. The in vitro antiproliferative activity of these extracts against several human-derived cancer cells (breast: MCF-7; cervical: HeLa; hepatocellular: HepG2) was also evaluated. The results showed that the Anthyllis vulneraria leaf extract was characterized by 17 different phenolic compounds, among which phenolic acids were the most abundant, while its flower extract exhibited higher contents of flavonoids. Furthermore, Anthyllis vulneraria extracts demonstrated a potent radical scavenging activity against methoxy radicals. Both extracts also significantly reduced the viability of the different cancer cell lines. The results of the current study suggested that Anthyllis vulneraria extracts are a promising source of antioxidant compounds with health benefits and pointed to their potential use for treating cancer and developing novel therapeutic agents.

Keywords: Anthyllis vulneraria; EPR; HPLC-MS; antiproliferative activity; human-derived cancer cells; methoxy radicals.

MeSH terms

  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Electron Spin Resonance Spectroscopy
  • HeLa Cells
  • Humans
  • Lotus*
  • Neoplasms* / drug therapy
  • Phenols / pharmacology
  • Plant Extracts / chemistry

Substances

  • Plant Extracts
  • Phenols
  • Antioxidants

Grants and funding

This research received no external funding.